This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH7JY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Irbesartan 150 mg tablets, a cardiovascular medication, with a total ceiling value of $6,617.42 and a completion date of December 4, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a comprehensive contracting mechanism for the DLA to procure a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal government agencies, particularly within the military and veterans' healthcare systems.
Generated 3/4/25, 11:23 AM